XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Oct. 28, 2023
Oct. 29, 2022
Cash flows from operating activities:    
Net income $ 22,620 $ 80,803
Adjustments to reconcile net income to net cash used for by operating activities:    
Amortization of deferred debt issuance costs 57 57
Impairment (gain) of assets   (398)
Loss on retirement plan terminations 4,231  
Gain from the sale of equipment (136)  
Depreciation and amortization 10,338 11,748
Deferred taxes, net of valuation allowance 9,232 (33,480)
Stock compensation expense 1,615 1,053
Board of directors' stock compensation 332 375
Changes in operating assets and liabilities:    
Accounts receivable (1,994) 1,094
Inventories (6,854) (25,052)
Prepaid expenses and other current assets (118) (1,892)
Other assets 55 (61)
Accounts payable 708 1,399
Operating leases, net 548 (5,590)
Accrued expenses and other liabilities (7,533) 113
Net cash used for operating activities 33,101 30,169
Cash flows from investing activities:    
Additions to property and equipment, net (10,404) (7,853)
Proceeds from sale of equipment 136  
Purchase of short-term investments (69,880)  
Maturity of short-term investments 21,007  
Net cash used for investing activities (59,141) (7,853)
Cash flows from financing activities:    
Repurchase of common stock (14,850) (12,728)
Tax withholdings paid related to net share settlements (758) (1,845)
Proceeds from the exercise of stock options 297 236
Net cash used for financing activities (15,311) (14,337)
Net increase (decrease) in cash and cash equivalents (41,351) 7,979
Cash and cash equivalents:    
Beginning of period 52,074 15,506
End of period $ 10,723 $ 23,485